Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Clinical Follow-up Study - PMCF Study, Serranator® Alto

NCT03538392 is registered in ClinicalTrials.gov with Cagent Vascular LLC as lead sponsor.

NCT NCT03538392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03538392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Clinical Follow-up Study - PMCF Study, Serranator® Alto
Lead sponsor
Cagent Vascular LLC
Phase
Observational
Overall status
Withdrawn
Start date
September 30, 2019
Completion date
December 31, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterio-venous fistula, arteriovenous graft, peripheral arterial disease